Imogen Kelso
Senior Associate
Imogen is a solicitor in the Litigation team, specialising in life sciences patent litigation. She has acted in disputes before the High Court and the Court of Appeal. Imogen also has experience coordinating multi-jurisdictional patent actions, including parallel UPC proceedings and EPO oppositions.
Imogen advises clients across the pharmaceutical and biotech sectors on complex patent disputes and related intellectual property matters. Her experience spans a wide range of technologies, including mRNA vaccines and medical devices.
She has broad experience in UK proceedings, from preliminary issues through to the determination of damages. She also has particular experience with cases involving litigation experiments.
Before joining Carpmaels & Ransford in 2026, Imogen practised at an international law firm in London. Imogen has a degree in Biochemistry from the University of Manchester, during which she undertook an industrial placement year investigating strains of Bordetella pertussis, the bacterium that causes whooping cough.
Outside of work Imogen enjoys running, going to the gym and theatre trips. She is also a keen netball fan.
Qualifications
- BSc Biochemistry with Industrial Experience (University of Manchester)
- Graduate Diploma in Law (University of Law, Guildford)
- Legal Practice Course (BPP Law School, London)
- Solicitor of England & Wales
- Diploma in IP Law and Practice (University of Oxford)
Key Matters & Cases
- Merck Sharp & Dohme v Wyeth (pneumococcal vaccines – High Court and Court of Appeal)
- BioNTech and Pfizer v CureVac (mRNA vaccines – High Court)
- Abbott v Dexcom (continuous glucose monitors – High Court)
- Abbott Diabetes Care v Sinocare and Menarini (continuous glucose monitors – High Court)
- Merck KGaA v Merck Sharp & Dohme (damages inquiry – High Court)